REQUEST A DEMO
Total
USD $0.00
Search more companies

Futuremeds Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising Agencies | Marketing Research and Public Opinion Polling | Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Futuremeds Sp. z o.o. Profile Updated: November 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

FutureMeds operates as a medical services and clinical research organization focused on running modern outpatient medical centers that combine commercial healthcare activity with preventive programs and clinical trial operations. Core business segments include clinical trials (end-to-end patient pathway support from qualification through participation and ongoing medical oversight), preventive screening and periodic health actions, and patient-facing medical consultation and care delivered through a network of centers and multidisciplinary medical teams; the organization positions clinical trials as a route to access innovative therapies and specialist care within structured research protocols. The operating model is supported by patient recruitment and engagement processes, clinical operations capabilities, and standardized patient support across study stages, complemented by educational content and guidance for participants and referring physicians. Geographic scope is national, delivered through a multi-site network in major Polish cities including Warsaw (multiple locations), Krakow, Lodz, Olsztyn, Gdynia and Wroclaw, enabling broad patient reach and multi-center trial execution within Poland. Key assets include the FutureMeds clinic network and research sites, experienced medical and clinical operations teams, operational experience accumulated through a high volume of completed clinical studies, and patient community reach supporting continuous recruitment for new studies. Strategic positioning is as a specialized platform at the intersection of healthcare delivery and clinical research, competing through nationwide site availability, participant-focused support, and capability to execute clinical trials and preventive programs at scale while maintaining a patient-oriented service standard.

Headquarters
Ul. Legnicka 16
Wroclaw; Dolnoslaskie; Postal Code: 53-673

Contact Details: Purchase the Futuremeds Sp. z o.o. report to view the information.

Website: http://www.medued.pl

Basic Information
Total Employees:
Purchase the Futuremeds Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Futuremeds Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Futuremeds Sp. z o.o. report to view the information.
Incorporation Date:
August 25, 2011
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Futuremeds Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
90.48%
Total operating revenue
86.08%
Operating Profit/Loss (EBIT)
289.39%
EBITDA
132.04%
Net Profit/Loss for the Period
486.52%
Total Assets
5.77%
Total Equity
90.78%
Operating Profit Margin (ROS)
7.12%
Net Profit Margin
5.98%
Return on Equity (ROE)
23.84%
Debt/Equity
-18.28%
Quick Ratio
0.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?